cladribine has been researched along with Cutaneous T-Cell Lymphoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogura, M | 1 |
| Piro, LD; Saven, A | 2 |
| Piro, LD | 1 |
| Kong, LR; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS | 1 |
| Hotta, T; Kinoshita, T; Kobayashi, Y; Kozuru, M; Narabayashi, M; Ogura, M; Ohashi, Y; Suzuki, R; Tobinai, K; Uike, N | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A | 1 |
| Juliusson, G; Liliemark, J; Pettersson, B | 1 |
4 review(s) available for cladribine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
[Cladribine].
Topics: Aged; Antineoplastic Agents; Cladribine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Female; Humans; Leukemia, Hairy Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged | 2003 |
2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
Topics: Cladribine; Humans; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous | 1993 |
Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms; Waldenstrom Macroglobulinemia | 1996 |
2-Chlorodeoxyadenosine treatment of lymphoma.
Topics: Adenosine Deaminase; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Pentostatin; Vidarabine; Waldenstrom Macroglobulinemia | 1996 |
2 trial(s) available for cladribine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoproliferative Disorders; Male; Middle Aged; Prognosis; Skin Neoplasms; Survival Rate | 1997 |
Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
Topics: Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1997 |
2 other study(ies) available for cladribine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
Topics: 2-Chloroadenosine; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents; Cladribine; Deoxyadenosines; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Time Factors | 1992 |
Determination of 2-chloro-2'-deoxyadenosine in human plasma.
Topics: 2-Chloroadenosine; Aged; Chromatography, High Pressure Liquid; Cladribine; Deoxyadenosines; Humans; Lymphoma, T-Cell, Cutaneous; Male | 1991 |